No Data
No Data
HUAKANG BIOMED: DISCLOSEABLE TRANSACTION AND ADVANCE TO ENTITY REPAYMENT ARRANGEMENT IN RELATION TO ACQUISITION OF 19% EQUITY INTEREST OF THE TARGET COMPANY AND PROVISION OF LOAN
HUAKANG BIOMED: ANNUAL REPORT 2023
Huakang Biomedical (08622) completed placement of 31 million shares to raise approximately HK$2.96 million
Huakang Biomedical (08622) issued an announcement. The conditions for the placement have been met, and on April 2, 2024...
Huakang Biomedical (08622.HK): Chen Jiansheng Resigns as Independent Non-Executive Director
Huakang Biomedical (08622.HK) announced that Chen Jiansheng resigned as an independent non-executive director of the company, a member of the Audit Committee and Nomination Committee in order to invest more time in his personal business and other matters, effective April 2, 2024.
HUAKANG BIOMED: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2023
Huakang Biomedical (08622) Fa Ying Guang expects annual shareholders' losses to be no more than 5.8 million yuan
Huakang Biomedical (08622) issued an announcement that it is expected that the company owner's losses during the period will end in December 2023...
No Data